Cafepharma Today

September 6 2024 - FDA concerned Iterum’s urinary tract infection drug could cause antimicrobial resistance
FDA concerned Iterum’s urinary tract infection drug could cause antimicrobial resistance
Edwards cuts more than 500 employees after critical care sale
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 mln valuation in US IPO
What 3 layoff stories reveal about pharma’s troubles
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Isis Technology Used to Attack Brain Tumors
Seeking Alpha
Friday, November 7, 2008 - 10:14am
tags:
Investors Liked What They Saw in Simcere's Q3 Report
Seeking Alpha
Friday, November 7, 2008 - 10:13am
tags:
Icagen posts loss on 75% revenue drop
Bizjournals.com
Friday, November 7, 2008 - 10:12am
tags:
Sanofi-Aventis cut to sell at UBS
Marketwatch
Friday, November 7, 2008 - 9:59am
tags:
PowerRatings Best of the Requests: GS, PFE, JNJ
Yahoo/Trading Markets
Friday, November 7, 2008 - 9:57am
tags:
Amgen to Review Business with Analysts
The Street.com
Friday, November 7, 2008 - 9:55am
tags:
Wyeth's Day In Court (WYE)
Investopedia
Friday, November 7, 2008 - 9:54am
tags:
Express Scripts, FBI, Probe Threat to Expose Records
Bloomberg
Friday, November 7, 2008 - 9:52am
tags:
Daiichi Sankyo Completes Purchase of 63.9% of Ranbaxy
Bloomberg
Friday, November 7, 2008 - 9:47am
tags:
Big Pharma’s Loss May Be Little Pharma’s Gain
Pharmalot
Thursday, November 6, 2008 - 9:52am
tags:
Burrill: Biotech faces "a long down-turn"
Fierce Biotech
Thursday, November 6, 2008 - 9:52am
tags:
A Byetta Beating
Motley Fool
Thursday, November 6, 2008 - 9:51am
tags:
Vermont docs received more secret payments
Fierce Pharma
Thursday, November 6, 2008 - 9:49am
tags:
SciClone's Phase III hepatitis trial fails endpoint
Trading Markets
Thursday, November 6, 2008 - 9:46am
tags:
King Pharmaceuticals swings to third-quarter profit
Marketwatch
Thursday, November 6, 2008 - 9:28am
tags:
CV Therapeutics says FDA approved Ranexa as first-line angina treatment, expanding uses
Yahoo/AP
Thursday, November 6, 2008 - 9:26am
tags:
NeuroSearch's Gamble May Not Pay off After Acomplia Failure
Bloomberg
Thursday, November 6, 2008 - 9:25am
tags:
AstraZeneca Pill May Gain $3 Billion, If Test Works
Bloomberg
Thursday, November 6, 2008 - 9:23am
tags:
A.P. Pharma cuts 18 people, posts loss
Bizjournals.com
Thursday, November 6, 2008 - 9:22am
tags:
Glaxo Trades U.S. For Asia
Forbes
Thursday, November 6, 2008 - 8:44am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble?
Drug Channels
The Healthcare Innovation Company's Value-Based Care Summit
Drug Channels
Embedding Into the Provider’s Workflow is Key to a Specialty Drug’s Success
Drug Channels
Drug Channels News Roundup, August 2024: My $0.02 on the IRA’s MFPs, UNC’s New PBM, Amazon vs. Retail, Fixing 340B, and Mark Cuban Lets Loose
Drug Channels
When Payers Become Producers: Inside the PBM Private-Labeling Trend
Drug Channels
Can Rite Aid Recover?
Drug Channels
IRA Reality Check: Four Strategies for Adapting Hub and Copay Programs
Drug Channels
Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (Video)
Drug Channels
Mid-Year Hub Review: Five Considerations for Staying Ahead of the Curve
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement, CNS - Los Angeles W, CA
Los Angeles, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Chicago, IL
Chicago, Illinois,
Otsuka
Sales Representative - Paid Training
Caldwell, Idaho, 83607
Bartlett Roofing
Pharmaceutical Sales Customer Engagement- Poughkeepsie, NY
Poughkeepsie, New York,
Otsuka
Medical Device Sales Specialist
Durham, North Carolina
B. Braun Medical Inc
Pharmaceutical Sales Customer Engagement - Parkersburg, WV
West Virginia, West Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement- Baltimore South
Baltimore, Maryland,
Otsuka
Pharmaceutical Sales Customer Engagement - Hinsdale, IL
Illinois, Illinois,
Otsuka
Regional Sales Manager - Central Texas
Dripping Springs, Texas, 78620
Clinical Pathology Laboratories, Inc
Regional Sales Manager - Central Texas
Georgetown, Texas, 78628
Clinical Pathology Laboratories, Inc
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information